Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,084,130

« Back to Dashboard

Which drugs does patent 7,084,130 protect, and when does it expire?

Patent 7,084,130 protects NAVSTEL and is included in one NDA.

This patent has eighteen patent family members in sixteen countries.

Summary for Patent: 7,084,130

Title:	Intraocular irrigating solution having improved flow characteristics
Abstract:	Improved intraocular irrigating solutions are described. The solutions have enhanced viscosities that reduce the risk of damage to intraocular surgical procedures by reducing the turbulence of the solutions and dampening the movement of tissue fragments and air bubbles. The solutions preferably also have modified surface tensions that more closely resemble the surface tension of the aqueous humor.
Inventor(s):	Shah; Mandar V. (Arlington, TX), Boukhny; Mikhail (Laguna Niguel, CA), Garner; William H. (Southlake, TX), Markwardt; Kerry L. (Mansfield, TX), Doshi; Uday (Randolph, NJ)
Assignee:	Alcon, Inc. (Hunenberg, CH)
Application Number:	10/240,449
Patent Claim Types: see list of patent claims	Composition; Formulation; Use;

Drugs Protected by US Patent 7,084,130

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Alcon Pharms Ltd	NAVSTEL	calcium chloride; dextrose; magnesium chloride; oxiglutatione; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate	SOLUTION;IRRIGATION	022193-001	Jul 24, 2008		DISCN	No	No	➤ Try a Free Trial	➤ Try a Free Trial	Y			USE AS AN INTRAOCULAR IRRIGATING SOLUTION DURING SURGICAL PROCEDURES INVOLVING PERFUSION OF THE EYE	➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted

Foreign Priority and PCT Information for Patent: 7,084,130

PCT Information
PCT Filed	December 11, 2001	PCT Application Number:	PCT/US01/48094
PCT Publication Date:	June 27, 2002	PCT Publication Number:	WO02/49614

International Family Members for US Patent 7,084,130

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	459337	➤ Try a Free Trial
Australia	2002239601	➤ Try a Free Trial
Australia	3960102	➤ Try a Free Trial
Brazil	0116353	➤ Try a Free Trial
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture

Express Scripts

Healthtrust

Cipla

Deloitte

Baxter

Argus Health

US Department of Justice

Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.